The Goto-Kakizaki (G/K) rat is an animal model of non-insulin-dependent diabetes mellitus, with early hyperglycaemia, hyperinsulinaemia, and insulin resistance. We have studied the effect of insulin on the activation of glycogen synthase in the G/K rat and in the original parent strain, the Wistar rat. After insulin injection, glycogen synthase I activity, glycogen synthase phosphatase activity and glucose 6-phosphate content in skeletal muscle were significantly increased in the Wistar rats. In the G/K rats, insulin injection resulted in a reduced activation of skeletal muscle glycogen synthase, which was not significant when compared with the control rats without insulin, and no increases in glycogen synthase phosphatase and glucose 6-phosphate were seen. In adipose tissue the activation of glycogen synthase by insulin was normal in the G/K rats. Previous investigations have shown that glucose disappearance rates are low in the G/K rat. However, stimulation of glucose transport was reported to be normal in the G/K rat. A defective activation of glucose accumulation into glycogen by skeletal muscle may contribute to explain the hyperglycaemia in the G/K rat. [Diabetologia (1994) 37: 885-888] Key words Glycogen synthase, insulin, Goto-Kakizaki rat, non-insulin-dependent diabetes mellitus, phosphatase, glucose 6-phosphate, skeletal muscle.
ity of the hepatic glycolytic and gluconeogenic pathways, indicating insulin resistance. Although the hyperglycaemia is moderate, neuropathy and glomerulopathy are present [3] . Interestingly, in common with human patients with NIDDM [4] and with another animal model of NIDDM, the macaca mulatta monkey [5] , the G/K rat shows deficient urinary chiroinositol levels [6] . Chiroinositol is an essential component of a putative insulin mediator which reproduces in vitro the effects of insulin on the activation of pyruvic dehydrogenase [7] and G3PAT (unpublished observations), and may also activate glucose transport in intact cells [8] .
Although this animal model of NIDDM has been known for many years, some of the best metabolic parameters of insulin action have not been studied. In particular, the effect of insulin on muscle glycogen synthase, of great importance in glycaemic control has not received attention. Here we report the results of comparative studies on the activation by insulin of glycogen synthase in the G/K rat and in normal were injected by the tail vein. For the G/K rats, six were used as controls and six were insulin-injected; ten Wistar rats were used for each condition. Five minutes after the injection, the skin covering the hind legs was removed, and 7 rain after the i.v. injection, muscle of the hind legs was removed and immediately (less than 5 s) frozen using Wallemberg clamps chilled in liquid N 2. No hypoglycaemia was observed in any of the insulin-injected animals at the end of the experiment. The muscle was powdered in stainless-steel mortars also chilled with liquid N2, and kept constantly frozen at -180 ~ Extracts were prepared and tested the same day, except for the assay of glucose 6-phosphate, which required lyophilization of the extracts. All results reported were obtained from the same animals. All individual values are average of duplicate determinations.
Enzymes and assay procedures. Glycogen synthase I was purified from rabbit skeletal muscle by the method of Takeda et al. [9] and was 3Zp-phosphorylated with rabbit liver casein kinase i and isolated as described previously [10] . For the assay of glucose 6-phosphate in muscle, i g aliquots of frozen tissue were homogenized in 6 ml of 10 % trifluoroacetic acid, centrifuged at 20000 x g for 20 min, and the supernatants lyophilized. The residue was dissolved in distilled water, lyophilized and re-dissolved at least four times, neutralized, and finally dissolved in i ml distilled water/g muscle. The solutions were filtered through 0.22%tm cellulose acetate filters and glucose 6-phosphate was determined with glucose 6-phosphate dehydrogenase and NADP in 0.2 ml of filtrate, as described by Kornberg [11] . To normalize the extracts, aliquots of the filtrates were diluted 1:100 in water and the absorption read at 260 nm. At this wave length tile absorption, due to the extracted nucleotide bases, is constant per gram of tissue. The average absorption of the 1 : 100 dilutions was 0.996 + 0.012/g muscle. For convenience it was considered 1.000.
Glycogen synthase activity was assayed by the method of Thomas et al. [12] , using (in mmol/1) 6.7 UDP-[UL]14C-glucose (127 cpm/nmol), 10 mg glycogen/ml, 50 Tris-HC1, pH 7.8, 20 EDTA, 50 potassium fluoride, and+ 10 glucose 6-phosphate. Tissues were homogenized in a Polytron for 20 s with 7 volumes (for skeletal muscle) or i volume (for fat pads) of 50Tris (10% glycerol, 150potassium fluoride, 15 EDTA, 5 DTT, i benzamidine, 2 mg glycogen/ml, 0.1 TLCK, 2.5 ~g leupeptin/ml) pH 7.96 at room temperature (Buffer T). The homogenates were centrifuged at 3000 x g for 20 min, and glycogen synthase activity _+ 10 mmol/1 glucose 6-phosphate measured in 20 ~1 of supernatant plus 40 ~1 of test mixture, 10 min incubation at 30 ~ All the tests were run in duplicate.
For the assay of glycogen synthase phosphatase activity, aliquots of frozen muscle were homogenized in a Polytron for 20 seconds with 2 volumes (w/v) of (in retool/l) 50 MOPS, (10 % glycerol, 5 EDTA, 2 EGTA, 2 mg glycogen/ml, 1 benzamidine, 0.1 TLCK, 2.5 ~tg leupeptin/ml) pH 7.35 (buffer M). The homogenates were centrifuged at 3000xg for 20 rain and the supernatants filtered through glass wool. Phosphatase activity of the extracts was measured by the release of 32p from 32p-labelled glycogen synthase, as described by Kato and Bishop [13] and modified as described previously [10] . Activity is expressed as cpm released from 3ZP-labelled glycogen synthase per mg of protein in the extracts.
The effect of insulin on hexose transport was measured in the gastrocnemius muscles of anaesthetized rats after eugly- At the end of the perfusion, the tissues were solubilized and the uptake of radioactivity determined basically as described by Turinsky et al. [14] .
Results

Activation of glycogen synthase by insulin. Insulin in-
jection resulted in activation of skeletal muscle glycogen synthase in the Wistar rats. The average glycogen synthase I content in the controls was 19.1 + 0.5 %, and in the insulin-injected animals 29.5 + 2.4 %, an increase of 54.5 %, p value 0.0005. In contrast, in the G/ K rats, the controls averaged 15.3 + 1.4 %, and the insulin-injected rats 18.6 + 1.6 %, an increase of 21.5 %, but not attaining significance (p= 0.157), Table 1 . Furthermore, the average total glycogen synthase in the G/K rat muscle extracts, 16.3 + 2.1 nmol.mg protein-<min -1, was significantly lower (p = 0.028) than in the Wistar rat muscle extracts, 24.2 + 2.4 nmol-mg protein-l-min-< In fat pads of G/K rats, however, the activation of glycogen synthase by insulin was much higher: the control glycogen synthase I averaged 
Activation of synthase phosphatase activity by insulin.
The effect of insulin injection on the synthase phosphatase activity of concentrated muscle extracts was measured as described in the Methods section. In the Wistar rats, the dephosphorylation of 32p-labelled glycogen synthase by concentrated muscle extracts was 72 % higher in the insulin-injected rats than in the controls (1039 _+ 64 cpm/mg protein in the extracts of insulin-injected rats; 604 + 46 cpm/mg protein in the control extracts). In the G/K rats, the basal phosphatase activity was significantly lower (p= 0.04) than in the Wistar rats, and insulin injection did not cause any significant increase in phosphatase activity (476 + 23 cpm/mg protein muscle control extracts; 488 + 18 cpm/mg protein in extracts from insulin-treated rats, p = 0.7). The comparative results from the three determinations are presented in Table 1 .
Discussion
There is a clear impairment of the activation of skeletal muscle glycogen synthase by insulin in the G/K rats when compared with the response of the parent strain, the Wistar rats. In agreement with previous reports on the muscle glycogen synthase activity in diabetic patients [15] , the G/K rats have a lower total glycogen synthase activity and basal per cent synthase I (p = 0.03) than the Wistar rats. The defect in the G/K rats appears complex, because not only is there no activation of glycogen synthase phosphatase, but also the control levels of phosphatase are lower in the G/K rat. Decreases in basal muscle glycogen synthase phosphatase activity have been reported in diabetic rabbits [16] , and low activities of phosphatase as well as little or no response to insulin have been reported in NIDDM patients in NIDDM [17] .
The elevated plasma glucose concentrations in the G/K rat do not appear to be due to a defect in the activation of the insulin receptor. The effect of insulin on [3H] 2-deoxyglucose uptake in muscles in 10-min 887 perfusions and in isolated adipocytes of Wistar and G/K rats, determined as described, and expressed as per cent increase over controls, appear to be practically identical. However, in the G/K rat, D-glucose uptake by isolated gastrocnemius, tested by the same method in perfusions of up to l-h, is only about 50 % of that observed with Wistar rats, and this defect correlates with the defective activation of glycogen synthase. It has been reported that various isolated tissues from the G/K rat are less reactive to the effect of insulin on glucose uptake than corresponding tissues in the control rat, particularly muscles with a high percentage of glycolytic fibres [18] . Disappearance rates calculated from glucose tolerance tests [19] or following i.p. glucose injection [20] have shown a marked impairment in the G/K rat, probably related to a decreased glucose-stimulated insulin release by the pancreas [19] . The defect in insulin secretion, coupled with the presently found defects in glucose uptake and in glycogen synthase activation, may possibly account for the hyperglycaemia in the G/K rat.
The activation by insulin of glycogen synthase appears essentially normal in epididymal fat pads of the G/K rat. In contrast, defective activation of G3PAT by insulin, as well as by chiroinositol-containing insulin mediators was found in adipocytes from G/K rats. However, if the G/K rats were treated for several days with insulin, the chiroinositol IPG mediator was found to activate G3PAT in cell-free homogenates of adipocytes, but, again, insulin alone had no effect (unpublished observations). Therefore, it would appear that different pathways of activation by insulin act upon G3PAT and glycogen synthase in adipose tissue, and that metabolic defects may affect only particular enzymes. In broken cell preparations insulin activates G3PAT, but not glycogen synthase, in agreement with the idea that at least two different pathways of metabolic activation are stimulated following insulin treatment.
In conclusion, the G/K rat appears to be an appropriate animal model of NIDDM in that there is a defective response of glycogen synthase activation by insulin. It differs from typical NIDDM in that the hyperglycaemia appears early in the life of the animals, and the rats are lean, not obsese. A typical defect in the activation of glycogen synthase by insulin appears to be present in muscle, but not adipose tissue. Concomitant decreases in glycogen synthase activity and activation by insulin, as well as low concentrations of glucose 6-phosphate, are also found in the G/K rat muscle.
